Quantum Biopharma Ltd. lost $8.20 per diluted share in fiscal year 2025. This represents an increase of 37.5% from the prior fiscal year. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters Quantum Biopharma Ltd. has filed alongside them.
FY2025 annual
EPS (Diluted)-$8.20
YoY+37.5%
Source SEC Filings (10-K/10-Q)Latest period FY2025, ended Dec 31, 2025ReportedCurrency USD
Annual figures, oldest first. Point at a bar to read its period.
QNTM EPS (Diluted) by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
What was Quantum Biopharma Ltd.'s diluted earnings per share in fiscal year 2025?
Quantum Biopharma Ltd. lost $8.20 per diluted share in fiscal year 2025.
How fast is Quantum Biopharma Ltd.'s diluted earnings per share growing?
Quantum Biopharma Ltd. (QNTM) diluted earnings per share rose by 37.5% year over year, from -$13.12 to -$8.20 in fiscal year 2025.
What was Quantum Biopharma Ltd.'s diluted earnings per share in the most recent quarter?
Quantum Biopharma Ltd. (QNTM) reported -$0.71 in diluted earnings per share in Q4 2025. This represents an increase of 65.5% from the same quarter a year earlier.
What does diluted earnings per share mean on a financial statement?
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Quantum Biopharma Ltd. (QNTM) reported on that line in every period on record.
